{"entity":{"type":"insider","cik":"0001733340","url":"/insider/0001733340","json_url":"/insider/0001733340.json","name":"GV 2017, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":4,"first":"2022-11-02","last":"2026-01-30","span_basis":"filed_date"},"name_variants":[{"name":"GV 2017, L.P.","source":"filing","n_filings":4,"first_seen":"2022-11-02","last_seen":"2026-01-30"}],"transactions":[{"id":5821726,"accession":"0001168404-26-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000007","line_url":"/filing/0001168404-26-000007","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2017 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2017, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; GV 2019, L.P.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1845308.0,"shares_display":"1,845,308","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":35060852.0,"total_display":"35,060,852.00","total_whole":"35,060,852","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-01-30","scope":"insider","n_lines":2},{"id":6730475,"accession":"0001209191-22-056122","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-056122","line_url":"/filing/0001209191-22-056122","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2017 GP, L.L.C.; GV 2017 GP, L.P.; Alphabet Inc.; GV 2017, L.P.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97166.0,"shares_display":"97,166","price_per_share":31.138577079431077,"price_display":"31.14","price_state":"stated","total_value":3025610.9805,"total_display":"3,025,610.98","total_whole":"3,025,611","shares_owned_after":4260940.0,"shares_owned_after_display":"4,260,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-08","scope":"insider","n_lines":6},{"id":6894392,"accession":"0001209191-22-055791","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-22-055791","line_url":"/filing/0001209191-22-055791","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019, L.P.; GV 2017, L.P.; GV 2017 GP, L.P.; GV 2017 GP, L.L.C.; GV 2019 GP, L.L.C.; Alphabet Inc.; GV 2019 GP, L.P.","owner_display_name":"GV 2019, L.P.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99137.0,"shares_display":"99,137","price_per_share":32.79328526786165,"price_display":"32.79","price_state":"stated","total_value":3251027.9216,"total_display":"3,251,027.92","total_whole":"3,251,028","shares_owned_after":1755.0,"shares_owned_after_display":"1,755","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-04","scope":"insider","n_lines":6},{"id":6894361,"accession":"0001209191-22-055791","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-055791","line_url":"/filing/0001209191-22-055791","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019, L.P.; GV 2017, L.P.; GV 2017 GP, L.P.; GV 2017 GP, L.L.C.; GV 2019 GP, L.L.C.; Alphabet Inc.; GV 2019 GP, L.P.","owner_display_name":"GV 2019, L.P.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57303.0,"shares_display":"57,303","price_per_share":35.94279501945797,"price_display":"35.94","price_state":"stated","total_value":2059629.983,"total_display":"2,059,629.98","total_whole":"2,059,630","shares_owned_after":4367128.0,"shares_owned_after_display":"4,367,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-04","scope":"insider","n_lines":6},{"id":6107339,"accession":"0001209191-22-055288","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-22-055288","line_url":"/filing/0001209191-22-055288","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2017 GP, L.L.C.; GV 2017, L.P.; GV 2019, L.P.; GV 2019 GP, L.P.; Alphabet Inc.; GV 2019 GP, L.L.C.; GV 2017 GP, L.P.","owner_display_name":"GV 2017 GP, L.L.C.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63926.0,"shares_display":"63,926","price_per_share":36.787940737728,"price_display":"36.79","price_state":"stated","total_value":2351705.8996,"total_display":"2,351,705.90","total_whole":"2,351,706","shares_owned_after":4389487.0,"shares_owned_after_display":"4,389,487","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-02","scope":"insider","n_lines":6},{"id":6107318,"accession":"0001209191-22-055288","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-22-055288","line_url":"/filing/0001209191-22-055288","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2017 GP, L.L.C.; GV 2017, L.P.; GV 2019, L.P.; GV 2019 GP, L.P.; Alphabet Inc.; GV 2019 GP, L.L.C.; GV 2017 GP, L.P.","owner_display_name":"GV 2017 GP, L.L.C.","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107393.0,"shares_display":"107,393","price_per_share":38.63682790684682,"price_display":"38.64","price_state":"stated","total_value":4149324.8594,"total_display":"4,149,324.86","total_whole":"4,149,325","shares_owned_after":4448777.0,"shares_owned_after_display":"4,448,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider","n_lines":8}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001788451","name":"Ethos Technologies Inc.","url":"/issuer/0001788451","role":"Ten percent owner","n_filings":1,"first_seen":"2026-01-30","last_seen":"2026-01-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Other","n_filings":3,"first_seen":"2022-11-02","last_seen":"2022-11-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001733340","retrieved_at":"2026-08-23T05:57:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}